IMI launches new Calls for proposals
A new Antimicrobial Resistance (AMR) Accelerator Programme is part of new Calls for proposals launched on 18 July by IMI. Of the other topics launched in the Calls, many address brain disorders and immune-mediated diseases. Among other things, the topics aim to make clinical trials more patient-centric, contribute to medicines safety, and apply blockchain technologies to the drug development and health sectors. Deadline for proposals: 24 October 2018.
IMI BROCHURE HIGHLIGHTS PROJECT SUCCESSES
IMI projects are accelerating the medicines development process, generating new scientific insights, and developing resources for open use by the research community. Furthermore, some of our projects are already delivering direct benefits to patients. Interested in concrete numbers and examples? Find out more about the impact and outputs of our projects in our new brochure, and learn how we are 'Carrying the torch for medical innovation'.
WATCH IMI video
Carrying the torch for medical innovation
Diseases keep changing, and infections we treated for decades can once again kill. By bringing together researchers from the public and private sectors, we are working to speed up medicines development and turn knowledge into treatments. Watch our video and share it!